Variant report
Variant | nsv517815 |
---|---|
Chromosome Location | chr2:35073607-35092762 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:12)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:12 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr2:35080062-35080354 | HepG2 | liver: | n/a | n/a |
2 | CTCF | chr2:35080300-35080370 | Lung_OC | lung: | n/a | n/a |
3 | CTCF | chr2:35084833-35084876 | Kidney_OC | kidney: | n/a | n/a |
4 | MAFK | chr2:35074228-35074307 | HepG2 | liver: | n/a | n/a |
5 | NRF1 | chr2:35076181-35076199 | GM12878 | blood: | n/a | n/a |
6 | POLR2A | chr2:35091271-35091477 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | POLR2A | chr2:35080041-35080225 | A549 | lung: | n/a | n/a |
8 | POLR2A | chr2:35078999-35079051 | GM12878 | blood: | n/a | n/a |
9 | POLR2A | chr2:35080028-35080037 | A549 | lung: | n/a | n/a |
10 | POLR2A | chr2:35073615-35073704 | A549 | lung: | n/a | n/a |
11 | STAT3 | chr2:35084416-35084567 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | STAT3 | chr2:35075152-35075156 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:35086981..35089694-chr2:35094487..35097235,2 | K562 | blood: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FAM98A-11 | chr2:35078527-35078731 | NONHSAT070061 |
2 | lnc-FAM98A-11 | chr2:35077532-35077593 | NONHSAT070061 |
3 | lnc-FAM98A-11 | chr2:35076849-35077075 | NONHSAT070061 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000226994 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs280691 | chr2:35073607-35073608 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs181522081 | chr2:35073630-35073631 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115173918 | chr2:35073631-35073632 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187506512 | chr2:35073647-35073648 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs141983328 | chr2:35073673-35073674 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553934849 | chr2:35073676-35073677 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369490923 | chr2:35073687-35073688 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs280692 | chr2:35073709-35073710 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs573107430 | chr2:35073715-35073716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555885290 | chr2:35073773-35073774 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs575607393 | chr2:35073778-35073779 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs143166723 | chr2:35073792-35073793 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs280693 | chr2:35073810-35073811 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs148268792 | chr2:35073811-35073812 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs374376103 | chr2:35073815-35073816 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs140407541 | chr2:35073817-35073818 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs150348758 | chr2:35073825-35073826 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs367912278 | chr2:35073832-35073833 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs543123083 | chr2:35073844-35073845 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs369442941 | chr2:35073863-35073864 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563006230 | chr2:35073875-35073876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs531703364 | chr2:35073913-35073914 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs578194677 | chr2:35073930-35073931 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs190295347 | chr2:35073937-35073938 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564986475 | chr2:35073984-35073985 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181023002 | chr2:35073991-35073992 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs72796911 | chr2:35074033-35074034 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs185036880 | chr2:35074059-35074060 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs138055339 | chr2:35074070-35074071 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs9308961 | chr2:35074107-35074108 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs536083931 | chr2:35074125-35074126 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs370229650 | chr2:35074153-35074154 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs280694 | chr2:35074155-35074156 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs538202223 | chr2:35074163-35074164 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs141998362 | chr2:35074172-35074173 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs115928823 | chr2:35074189-35074190 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs534505493 | chr2:35074200-35074201 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs554197782 | chr2:35074210-35074211 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574163526 | chr2:35074234-35074235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs145437500 | chr2:35074259-35074260 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs146332809 | chr2:35074289-35074290 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs114387312 | chr2:35074299-35074300 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs72796913 | chr2:35074300-35074301 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs540796315 | chr2:35074317-35074318 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs115887835 | chr2:35074378-35074379 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs375405056 | chr2:35074382-35074383 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs549817095 | chr2:35074385-35074386 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs547645813 | chr2:35074389-35074390 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs561060655 | chr2:35074394-35074395 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs138186027 | chr2:35074398-35074399 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:35057200-35080400 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
2 | chr2:35073000-35075600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr2:35073000-35075800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
4 | chr2:35073000-35075800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr2:35073200-35075200 | Enhancers | Primary hematopoietic stem cells | blood |
6 | chr2:35073800-35074200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
7 | chr2:35074600-35081400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
8 | chr2:35075600-35078600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr2:35075800-35078200 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
10 | chr2:35075800-35078600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr2:35076600-35076800 | Enhancers | Pancreas | Pancrea |
12 | chr2:35076600-35077000 | Enhancers | Liver | Liver |
13 | chr2:35076800-35079000 | Weak transcription | Pancreas | Pancrea |
14 | chr2:35078200-35079600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
15 | chr2:35078600-35079000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
16 | chr2:35078600-35079600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr2:35079000-35079200 | Enhancers | Pancreas | Pancrea |